Hyperinsulinemia secondary to chronic administration of mazindol and d-amphetamine
- PMID: 4948438
- DOI: 10.1097/00000441-197106000-00005
Hyperinsulinemia secondary to chronic administration of mazindol and d-amphetamine
Similar articles
-
Mazindol, a new non-amphetamine anorexigenic agent.J Clin Pharmacol New Drugs. 1972 Nov-Dec;12(11):453-8. doi: 10.1002/j.1552-4604.1972.tb00246.x. J Clin Pharmacol New Drugs. 1972. PMID: 4563662 Clinical Trial. No abstract available.
-
A double blind controlled trial of a new anorectic agent AN448.N Z Med J. 1975 Jun 25;81(542):546-9. N Z Med J. 1975. PMID: 1099491 Clinical Trial.
-
Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.Diabete Metab. 1978 Sep;4(3):193-9. Diabete Metab. 1978. PMID: 361463 Clinical Trial.
-
[Glucose tolerance, insulin and lipids after one week's administration of fenfluramine to overweight patients (author's transl)].MMW Munch Med Wochenschr. 1975 Nov 28;117(48):1925-8. MMW Munch Med Wochenschr. 1975. PMID: 813120 Clinical Trial. German.
-
Metabolic effects of stravation in newborn pigs.Nutr Rev. 1971 Feb;29(2):45-7. doi: 10.1111/j.1753-4887.1971.tb07235.x. Nutr Rev. 1971. PMID: 4938577 Review. No abstract available.
Cited by
-
Anorectic drugs: use in general practice.Drugs. 1976;11(5):378-93. doi: 10.2165/00003495-197611050-00002. Drugs. 1976. PMID: 782835 Review.
-
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD004096. doi: 10.1002/14651858.CD004096.pub2. Cochrane Database Syst Rev. 2005. PMID: 15674929 Free PMC article.
-
Ciclazindol: an oral agent with weight reducing properties and hypoglycaemic activity.Eur J Clin Pharmacol. 1983;25(1):41-5. doi: 10.1007/BF00544012. Eur J Clin Pharmacol. 1983. PMID: 6352281 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources